domingo, 22 de mayo de 2011

National Quality Measures Clearinghouse | Cancer - anorexia and weight loss: RAND Corporation


RAND Corporation
Cancer - anorexia and weight loss: percentage of patients treated with an appetite stimulant for anorexia who had an assessment before or on the next visit to the same outpatient site of whether or not there was an improvement in anorexia.

full-text:
National Quality Measures Clearinghouse | Cancer - anorexia and weight loss: percentage of patients treated with an appetite stimulant for anorexia who had an assessment before or on the next visit to the same outpatient site of whether or not there was an improvement in anorexia.


Cancer - anorexia and weight loss: percentage of patients treated with enteral or parenteral nutrition who had an assessment prior to starting nutrition that there was difficulty maintaining nutrition due to significant gastrointestinal issues and that expected life expectancy was at least one month.

full-text:
National Quality Measures Clearinghouse | Cancer - anorexia and weight loss: percentage of patients treated with enteral or parenteral nutrition who had an assessment prior to starting nutrition that there was difficulty maintaining nutrition due to significant gastrointestinal issues and that expected life expectancy was at least one month.


Cancer - anorexia and weight loss: percentage of patients who presented for an initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer at a cancer-related outpatient site for whom there was an assessment for the presence or absence of anorexia or dysphagia.

full-text:
National Quality Measures Clearinghouse | Cancer - anorexia and weight loss: percentage of patients who presented for an initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer at a cancer-related outpatient site for whom there was an assessment for the presence or absence of anorexia or dysphagia.

No hay comentarios: